Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

Similar articles for PubMed (Select 18663149)

1.

High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival.

Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K, Brooks-Wilson A, Spinelli JJ, Eaves CJ, Eaves AC, Horsman DE, Lam WL, Karsan A.

Blood. 2008 Oct 15;112(8):3412-24. doi: 10.1182/blood-2007-11-122028. Epub 2008 Jul 28.

2.

High resolution single nucleotide polymorphism array reveals cryptic indicating information about myelodysplastic syndrome-related myeloid malignancies.

Chi K, Li Y, Ding Q, Xu L, Chen Y, Wang X.

Leuk Lymphoma. 2015 Jun 19:1-4. [Epub ahead of print] No abstract available.

PMID:
25721904
3.

Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.

Patel B, Hirsch C, Clemente M, Sekeres M, Makishima H, Maciejewski JP.

Int J Hematol. 2015 Mar;101(3):213-8. doi: 10.1007/s12185-015-1747-7. Epub 2015 Feb 18.

PMID:
25690487
4.

Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes.

Noronha TR, Rohr SS, Chauffaille Mde L.

Rev Bras Hematol Hemoter. 2015 Jan-Feb;37(1):48-54. doi: 10.1016/j.bjhh.2014.09.011. Epub 2014 Nov 21.

5.

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.

Gerstung M, Pellagatti A, Malcovati L, Giagounidis A, Porta MG, Jädersten M, Dolatshad H, Verma A, Cross NC, Vyas P, Killick S, Hellström-Lindberg E, Cazzola M, Papaemmanuil E, Campbell PJ, Boultwood J.

Nat Commun. 2015 Jan 9;6:5901. doi: 10.1038/ncomms6901.

6.

Array comparative genomic hybridisation testing in CHD.

Hightower HB, Robin NH, Mikhail FM, Ambalavanan N.

Cardiol Young. 2014 Oct 8:1-18. [Epub ahead of print]

PMID:
25296170
7.

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.

Vercauteren SM, Starczynowski DT, Sung S, McNeil K, Salski C, Jensen CL, Bruyere H, Lam WL, Karsan A.

Br J Haematol. 2012 Feb;156(3):409-12. No abstract available.

9.

Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine.

Cluzeau T, Moreilhon C, Mounier N, Karsenti JM, Gastaud L, Garnier G, Re D, Montagne N, Gutnecht J, Auberger P, Fuzibet JG, Cassuto JP, Raynaud S.

Blood Cancer J. 2013 Nov 1;3:e155. doi: 10.1038/bcj.2013.52.

10.

[Genomic abnormalities and pathophysiology in myelodysplastic syndrome].

Chiba S.

Rinsho Ketsueki. 2013 Oct;54(10):1687-96. Review. Japanese. No abstract available.

PMID:
24064818
11.

Diagnostic methods of lung cancer and its subtypes by comparative genomic hybridization.

Garnis C.

Expert Opin Med Diagn. 2007 Dec;1(4):541-4. doi: 10.1517/17530059.1.4.541.

PMID:
23496360
12.

High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes.

Gianelli U, Fracchiolla NS, Bucciarelli P, Ferla V, Boiocchi L, Savi F, Moro A, Reda G, Bosari S, Cortelezzi A.

Am J Clin Pathol. 2013 Mar;139(3):380-7. doi: 10.1309/AJCP5O3YBKTGGWNQ.

13.

Array-CGH in childhood MDS.

Tauscher M, Praulich I, Steinemann D.

Methods Mol Biol. 2013;973:267-78. doi: 10.1007/978-1-62703-281-0_17.

PMID:
23412796
14.

The use of cytogenetic microarrays in myelodysplastic syndrome characterization.

Shaffer LG, Ballif BC, Schultz RA.

Methods Mol Biol. 2013;973:69-85. doi: 10.1007/978-1-62703-281-0_5.

PMID:
23412784
15.
16.

Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.

Jacoby MA, Walter MJ.

Expert Rev Mol Diagn. 2012 Apr;12(3):253-64. doi: 10.1586/erm.12.18. Review.

PMID:
22468816
17.

Development of a multiplex PCR assay for the detection of genomic copy number changes in myelodysplastic syndromes.

Stamatoullas A, Waultier A, Jardin F, Callat MP, Parmentier F, Burgot C, Penther D, Tilly H, Bastard C.

Leuk Res. 2012 May;36(5):e93-7. doi: 10.1016/j.leukres.2012.01.007. Epub 2012 Feb 16. No abstract available.

PMID:
22341430
18.

From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype.

Merkerova MD, Bystricka D, Belickova M, Krejcik Z, Zemanova Z, Polak J, Hajkova H, Brezinova J, Michalova K, Cermak J.

Genes Chromosomes Cancer. 2012 May;51(5):419-28. doi: 10.1002/gcc.21927. Epub 2012 Jan 17.

PMID:
22250017
19.

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.

Kolquist KA, Schultz RA, Furrow A, Brown TC, Han JY, Campbell LJ, Wall M, Slovak ML, Shaffer LG, Ballif BC.

Cancer Genet. 2011 Nov;204(11):603-28. doi: 10.1016/j.cancergen.2011.10.004.

PMID:
22200086
20.

The network properties of myelodysplastic syndromes pathogenesis revealed by an integrative systems biological method.

Ren X, Zhou X, Chang CC.

Mol Biosyst. 2011 Jun;7(6):2048-54. doi: 10.1039/c1mb05018d. Epub 2011 Apr 19.

PMID:
21505650
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk